1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

Food and Drug Administration (FDA) joins Pharma IQ's Ensuring Adventitious Agent Safety in Biologics

Santosh Nanda and Rebecca Sheets from the FDA announced their official participation at Pharma IQ's Ensuring Adventitious Agent Safety in Biologics conference

PRLog - Aug. 5, 2011 - VICTORIA, U.K. -- Santosh Nanda, Microbiologist/ Primary Reviewer, CBER, FDA and Rebecca Sheets, Vaccine Scientific and Regulatory Specialist, NIH/NIAID have announced their official participation at the Ensuring Adventitious Agent Safety in Biologics conference due to take place from the 17th October to 19th October 2011 in NH München Dornach, Munich, Germany .

This year's conference has expanded its focus from solely viral safety to encompass mycoplasma, TSE and bacteria. The event will have a strong focus on prevention and regulatory compliance as well as offering a nature of discussion based and interactive sessions.

Systematically Characterising Adventitious Agent Tests for Biologics

At the conference, Rebecca Sheets will be discussing the policy perspective on adapting new testing methodologies, she will assess the breadth and sensitivity of routine adventitious agent tests and will cover the harmonisation of  test methods (both existing and emerging).

On the other hand,  Santosh Nanda will be sharing a regulatory perspective on how to evaluate the Safety of New Flu Vaccine Development Methods, he will assess the risks of the cell-based development process and will also Investigate the challenges and benefits of utilising cell based vaccine development and developing regulatory guidance to govern the process.

The Ensuring Adventitious Agent Safety in Biologics conference aims at creating effective strategies to mitigate risk and enable prompt remediation of viral, prion and mycoplasma contamination - it will provide an interactive forum for learning best practices, keeping abreast of new developments and forging lasting business relationships.

20 biotech and biopharma experts are getting together this October to share updates and insights on how to escape contamination and get your products to market safely, speedily and successfully.

To view the conference programme (including full speaker and session information) visit http://www.adventitiousagentsevent.com/redForms.aspx?id=5...

Find event details and registration information on
http://www.adventitiousagentsevent.com/news1 or email enquire@iqpc.co.uk

Media contact: Veronica Araujo, +44 (0)20 7368 9748, veronica.araujo@iqpc.co.uk or visit http://www.adventitiousagentsevent.com/news1

Press are invited to attend this important industry forum, if you would like to a complimentary press pass please email Veronica Araujo (veronica.araujo@iqpc.co.uk)

--- End ---

Click to Share

Contact Email:
***@iqpc.co.uk Email Verified
Source:Pharma IQ
Location:Victoria - London, Greater - United Kingdom
Industry:Biotech, Science, Environment
Tags:quality control, quality assurance, qa, qc, contamination, microbiology, viral, prion, mycoplasma, adventitious
Verified Account Email Address
Verified Account Phone Number

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “


Trending News...

  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
Click to Share